{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "SARS-CoV-2",
      "biosensors",
      "chip",
      "diagnostics",
      "microfluidic"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "35323449",
  "DateCompleted": {
    "Year": "2022",
    "Month": "04",
    "Day": "06"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "05",
    "Day": "31"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2022",
        "Month": "03",
        "Day": "17"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "179",
      "10.3390/bios12030179"
    ],
    "Journal": {
      "ISSN": "2079-6374",
      "JournalIssue": {
        "Volume": "12",
        "Issue": "3",
        "PubDate": {
          "Year": "2022",
          "Month": "Mar",
          "Day": "17"
        }
      },
      "Title": "Biosensors",
      "ISOAbbreviation": "Biosensors (Basel)"
    },
    "ArticleTitle": "Microfluidics-Based Biosensing Platforms: Emerging Frontiers in Point-of-Care Testing SARS-CoV-2 and Seroprevalence.",
    "Abstract": {
      "AbstractText": [
        "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the ongoing COVID-19 (coronavirus disease-2019) outbreak and has unprecedentedly impacted the public health and economic sector. The pandemic has forced researchers to focus on the accurate and early detection of SARS-CoV-2, developing novel diagnostic tests. Among these, microfluidic-based tests stand out for their multiple benefits, such as their portability, low cost, and minimal reagents used. This review discusses the different microfluidic platforms applied in detecting SARS-CoV-2 and seroprevalence, classified into three sections according to the molecules to be detected, i.e., (1) nucleic acid, (2) antigens, and (3) anti-SARS-CoV-2 antibodies. Moreover, commercially available alternatives based on microfluidic platforms are described. Timely and accurate results allow healthcare professionals to perform efficient treatments and make appropriate decisions for infection control; therefore, novel developments that integrate microfluidic technology may provide solutions in the form of massive diagnostics to control the spread of infectious diseases."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Tecnologico de Monterrey, School of Engineering and Sciences, Monterrey 64849, Nuevo Le\u00f3n, Mexico."
          }
        ],
        "LastName": "Flores-Contreras",
        "ForeName": "Elda A",
        "Initials": "EA"
      },
      {
        "Identifier": [
          "0000-0002-3022-7746"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Tecnologico de Monterrey, School of Engineering and Sciences, Monterrey 64849, Nuevo Le\u00f3n, Mexico."
          }
        ],
        "LastName": "Gonz\u00e1lez-Gonz\u00e1lez",
        "ForeName": "Reyna Berenice",
        "Initials": "RB"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laboratorio de Fisiolog\u00eda Molecular y Estructural, Facultad de Ciencias Biol\u00f3gicas, Universidad Aut\u00f3noma de Nuevo Le\u00f3n, San Nicol\u00e1s de los Garza 66455, Nuevo Le\u00f3n, Mexico."
          }
        ],
        "LastName": "Rodr\u00edguez-S\u00e1nchez",
        "ForeName": "Iram P",
        "Initials": "IP"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Delee Corp., Mountain View, CA 94041, USA."
          }
        ],
        "LastName": "Yee-de Le\u00f3n",
        "ForeName": "Juan F",
        "Initials": "JF"
      },
      {
        "Identifier": [
          "0000-0003-4855-2720"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Tecnologico de Monterrey, School of Engineering and Sciences, Monterrey 64849, Nuevo Le\u00f3n, Mexico."
          }
        ],
        "LastName": "Iqbal",
        "ForeName": "Hafiz M N",
        "Initials": "HMN"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laboratorio de Fisiolog\u00eda Molecular y Estructural, Facultad de Ciencias Biol\u00f3gicas, Universidad Aut\u00f3noma de Nuevo Le\u00f3n, San Nicol\u00e1s de los Garza 66455, Nuevo Le\u00f3n, Mexico."
          }
        ],
        "LastName": "Gonz\u00e1lez-Gonz\u00e1lez",
        "ForeName": "Everardo",
        "Initials": "E"
      }
    ],
    "GrantList": [
      {
        "GrantID": "CVU. 735340",
        "Agency": "Consejo Nacional de Ciencia y Tecnolog\u00eda",
        "Country": ""
      },
      {
        "GrantID": "CVU. 735340",
        "Agency": "Monterrey Institute of Technology and Higher Education",
        "Country": ""
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Switzerland",
    "MedlineTA": "Biosensors (Basel)",
    "NlmUniqueID": "101609191",
    "ISSNLinking": "2079-6374"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antibodies, Viral"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Antibodies, Viral"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Biosensing Techniques"
    },
    {
      "QualifierName": [
        "diagnosis",
        "epidemiology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Microfluidics"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Point-of-Care Systems"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Point-of-Care Testing"
    },
    {
      "QualifierName": [
        "immunology",
        "isolation & purification"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Seroepidemiologic Studies"
    }
  ],
  "CoiStatement": "The authors declare no conflict of interest."
}